Search Results
Search results for "Faust pharmaceutical"
Results found for "Faust pharmaceutical"
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
He received his Ph.D. in Pharmaceutics from the University of Minnesota in 2022, studying the pharmacokinetics
- Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem
GPCR pharmacology, receptor signaling, and drug discovery evolved inside one of the worldâs largest pharmaceutical
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
She has worked across pharmaceutical, biotechnology, and academic settings, including a research placement
- Alexander Hauser: GPCR Pharmacogenomics and Precision Psychiatry | Dr. GPCR Ecosystem
He received the âHC Ărsted Research talent prizeâ and âBayer Pharmaceuticals Ph.D.
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
what happens when taste pharmacology intersects with drug development - a collision that, for most of pharmaceutical
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
Katarina Nemec " I am a pharmacist with an interest in systems pharmacology and precision medicine.
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
I can imagine myself in a biotech or pharmaceutical environment where Iâm helping guide drug development
- YC-VC Insights | Dr. GPCR Ecosystem
Fast-track your biotech investments with VC Insights. Home About Services News Get in Touch Welcome VC Insights Fast Track Your Next Biotech Bet Get decision-grade data, vetted CROs, and expert guidanceâso you move fast and invest smarter. Fast Track My Discovery The wrong CROâor wrong experimentsâcan burn months and millions You're not here You're backing science that needs to move fast.
- Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem
inhibitors may rescue oral delivery of opioid adjuncts, and how a student's side project on intermittent fasting problem of oral delivery, and how a graduate student's skeptically-received side project on intermittent fasting index, signal organization downstream of opioid receptors, and the unexpected effects of intermittent fasting opioid receptor Downstream pharmacology as an underexplored route to safer opioid therapy Intermittent fasting Graduate student David Duran wanted to test intermittent fasting in mice. Dr.
- YC-BioTech | Dr. GPCR Ecosystem
platform, or early data and turn it into a strategic roadmap with clear decisions, timelines, and results fast Others bring me in to fix one key problem fast. 03 What's the typical outcome?
- Dr. Rosie Dawaliby | Dr. GPCR Ecosystem
And since then, my incredible adventure as CEO of this fast-growing company started and is continuing
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
In 3 fast steps , we turn your bottlenecks into momentum: 1.
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
At Celtarys, the focus is on enabling fast, customizable development of fluorescent ligands and chemical
- Yamina's Corner | Dr. GPCR Ecosystem
Fast-Track Discovery CRO Partnership & Optimization For Contract Research Organizations Elevate Scientific
- Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem
Fast release cycles are a signal of infrastructure maturity.
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
The DARPA non-psychedelic psychedelic project is real, early, and moving fast.
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
native cell biology matters 38:05 Advice for young scientists: think broadly, resist narrowing too fast
- Your GPCR Order Has Arrived! â Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
. đ„ Act Fast â Only 25 Spots Available! ⥠Donât miss out! Premium Members save 25% on enrollment!
- GPCR Courses | Dr. GPCR Ecosystem
The GPCR Field Is Advancing Fast â Don't Fall Behind Stay ahead in drug discovery with insights from















